Shopping Cart 0
Cart Subtotal
USD 0

Global Parkinsons Disease Drug Market Report 2019, Competitive Landscape, Trends and Opportunities

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 2960

Access to Printed Report; No Soft Copy
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
USD 3460

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 4500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 4500

Details

The Parkinsons Disease Drug market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.

The report mainly studies the size, recent trends and development status of the Parkinsons Disease Drug market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Parkinsons Disease Drug market.

Major players in the global Parkinsons Disease Drug market include:

GSK

Orion

Desitin Arzneimittel

F.Hoffmann-La Roche

Akorn

Abbvie

Valeant

Endo Pharmaceuticals

Kyowa Hakko Kirin Pharma

Teva Pharmaceutical

Novartis

Boehringer Ingelheim

Apokyn

H.Lundbeck

Merck

Stada Arzneimittel

Astellas Pharma

On the basis of types, the Parkinsons Disease Drug market is primarily split into:

Type 1

Type 2

Type 3

On the basis of applications, the market covers:

Application 1

Application 2

Application 3

Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:

United States

Europe (Germany, UK, France, Italy, Spain, Russia, Poland)

China

Japan

India

Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)

Central and South America (Brazil, Mexico, Colombia)

Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)

Other Regions

Chapter 1 provides an overview of Parkinsons Disease Drug market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Parkinsons Disease Drug market by type, application, and region are also presented in this chapter.

Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.

Chapter 3 provides a full-scale analysis of major players in Parkinsons Disease Drug industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.

Chapter 4 gives a worldwide view of Parkinsons Disease Drug market. It includes production, market share revenue, price, and the growth rate by type.

Chapter 5 focuses on the application of Parkinsons Disease Drug, by analyzing the consumption and its growth rate of each application.

Chapter 6 is about production, consumption, export, and import of Parkinsons Disease Drug in each region.

Chapter 7 pays attention to the production, revenue, price and gross margin of Parkinsons Disease Drug in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.

Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.

Chapter 9 introduces the industrial chain of Parkinsons Disease Drug. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.

Chapter 10 provides clear insights into market dynamics.

Chapter 11 prospects the whole Parkinsons Disease Drug market, including the global production and revenue forecast, regional forecast. It also foresees the Parkinsons Disease Drug market by type and application.

Chapter 12 concludes the research findings and refines all the highlights of the study.

Chapter 13 introduces the research methodology and sources of research data for your understanding.

Years considered for this report:

Historical Years: 2014-2018

Base Year: 2019

Estimated Year: 2019

Forecast Period: 2019-2026

READ MORE

Table Of Content

Scope

Table of Contents

1 Parkinsons Disease Drug Market Overview

1.1 Product Overview and Scope of Parkinsons Disease Drug

1.2 Parkinsons Disease Drug Segment by Type

1.2.1 Global Parkinsons Disease Drug Production and CAGR (%) Comparison by Type (2014-2026)

1.2.2 The Market Profile of Type 1

1.2.3 The Market Profile of Type 2

1.2.4 The Market Profile of Type 3

1.3 Global Parkinsons Disease Drug Segment by Application

1.3.1 Parkinsons Disease Drug Consumption (Sales) Comparison by Application (2014-2026)

1.3.2 The Market Profile of Application 1

1.3.3 The Market Profile of Application 2

1.3.4 The Market Profile of Application 3

1.4 Global Parkinsons Disease Drug Market by Region (2014-2026)

1.4.1 Global Parkinsons Disease Drug Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)

1.4.2 United States Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.3 Europe Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.3.1 Germany Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.3.2 UK Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.3.3 France Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.3.4 Italy Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.3.5 Spain Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.3.6 Russia Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.3.7 Poland Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.4 China Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.5 Japan Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.6 India Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.7 Southeast Asia Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.7.1 Malaysia Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.7.2 Singapore Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.7.3 Philippines Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.7.4 Indonesia Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.7.5 Thailand Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.7.6 Vietnam Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.8 Central and South America Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.8.1 Brazil Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.8.2 Mexico Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.8.3 Colombia Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.9 Middle East and Africa Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.9.1 Saudi Arabia Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.9.2 United Arab Emirates Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.9.3 Turkey Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.9.4 Egypt Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.9.5 South Africa Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.9.6 Nigeria Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.5 Global Market Size (Value) of Parkinsons Disease Drug (2014-2026)

1.5.1 Global Parkinsons Disease Drug Revenue Status and Outlook (2014-2026)

1.5.2 Global Parkinsons Disease Drug Production Status and Outlook (2014-2026)

2 Global Parkinsons Disease Drug Market Landscape by Player

2.1 Global Parkinsons Disease Drug Production and Share by Player (2014-2019)

2.2 Global Parkinsons Disease Drug Revenue and Market Share by Player (2014-2019)

2.3 Global Parkinsons Disease Drug Average Price by Player (2014-2019)

2.4 Parkinsons Disease Drug Manufacturing Base Distribution, Sales Area and Product Type by Player

2.5 Parkinsons Disease Drug Market Competitive Situation and Trends

2.5.1 Parkinsons Disease Drug Market Concentration Rate

2.5.2 Parkinsons Disease Drug Market Share of Top 3 and Top 6 Players

2.5.3 Mergers & Acquisitions, Expansion

3 Players Profiles

3.1 GSK

3.1.1 GSK Basic Information, Manufacturing Base, Sales Area and Competitors

3.1.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.1.3 GSK Parkinsons Disease Drug Market Performance (2014-2019)

3.1.4 GSK Business Overview

3.2 Orion

3.2.1 Orion Basic Information, Manufacturing Base, Sales Area and Competitors

3.2.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.2.3 Orion Parkinsons Disease Drug Market Performance (2014-2019)

3.2.4 Orion Business Overview

3.3 Desitin Arzneimittel

3.3.1 Desitin Arzneimittel Basic Information, Manufacturing Base, Sales Area and Competitors

3.3.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.3.3 Desitin Arzneimittel Parkinsons Disease Drug Market Performance (2014-2019)

3.3.4 Desitin Arzneimittel Business Overview

3.4 F.Hoffmann-La Roche

3.4.1 F.Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Competitors

3.4.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.4.3 F.Hoffmann-La Roche Parkinsons Disease Drug Market Performance (2014-2019)

3.4.4 F.Hoffmann-La Roche Business Overview

3.5 Akorn

3.5.1 Akorn Basic Information, Manufacturing Base, Sales Area and Competitors

3.5.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.5.3 Akorn Parkinsons Disease Drug Market Performance (2014-2019)

3.5.4 Akorn Business Overview

3.6 Abbvie

3.6.1 Abbvie Basic Information, Manufacturing Base, Sales Area and Competitors

3.6.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.6.3 Abbvie Parkinsons Disease Drug Market Performance (2014-2019)

3.6.4 Abbvie Business Overview

3.7 Valeant

3.7.1 Valeant Basic Information, Manufacturing Base, Sales Area and Competitors

3.7.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.7.3 Valeant Parkinsons Disease Drug Market Performance (2014-2019)

3.7.4 Valeant Business Overview

3.8 Endo Pharmaceuticals

3.8.1 Endo Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors

3.8.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.8.3 Endo Pharmaceuticals Parkinsons Disease Drug Market Performance (2014-2019)

3.8.4 Endo Pharmaceuticals Business Overview

3.9 Kyowa Hakko Kirin Pharma

3.9.1 Kyowa Hakko Kirin Pharma Basic Information, Manufacturing Base, Sales Area and Competitors

3.9.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.9.3 Kyowa Hakko Kirin Pharma Parkinsons Disease Drug Market Performance (2014-2019)

3.9.4 Kyowa Hakko Kirin Pharma Business Overview

3.10 Teva Pharmaceutical

3.10.1 Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors

3.10.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.10.3 Teva Pharmaceutical Parkinsons Disease Drug Market Performance (2014-2019)

3.10.4 Teva Pharmaceutical Business Overview

3.11 Novartis

3.11.1 Novartis Basic Information, Manufacturing Base, Sales Area and Competitors

3.11.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.11.3 Novartis Parkinsons Disease Drug Market Performance (2014-2019)

3.11.4 Novartis Business Overview

3.12 Boehringer Ingelheim

3.12.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Competitors

3.12.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.12.3 Boehringer Ingelheim Parkinsons Disease Drug Market Performance (2014-2019)

3.12.4 Boehringer Ingelheim Business Overview

3.13 Apokyn

3.13.1 Apokyn Basic Information, Manufacturing Base, Sales Area and Competitors

3.13.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.13.3 Apokyn Parkinsons Disease Drug Market Performance (2014-2019)

3.13.4 Apokyn Business Overview

3.14 H.Lundbeck

3.14.1 H.Lundbeck Basic Information, Manufacturing Base, Sales Area and Competitors

3.14.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.14.3 H.Lundbeck Parkinsons Disease Drug Market Performance (2014-2019)

3.14.4 H.Lundbeck Business Overview

3.15 Merck

3.15.1 Merck Basic Information, Manufacturing Base, Sales Area and Competitors

3.15.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.15.3 Merck Parkinsons Disease Drug Market Performance (2014-2019)

3.15.4 Merck Business Overview

3.16 Stada Arzneimittel

3.16.1 Stada Arzneimittel Basic Information, Manufacturing Base, Sales Area and Competitors

3.16.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.16.3 Stada Arzneimittel Parkinsons Disease Drug Market Performance (2014-2019)

3.16.4 Stada Arzneimittel Business Overview

3.17 Astellas Pharma

3.17.1 Astellas Pharma Basic Information, Manufacturing Base, Sales Area and Competitors

3.17.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.17.3 Astellas Pharma Parkinsons Disease Drug Market Performance (2014-2019)

3.17.4 Astellas Pharma Business Overview

4 Global Parkinsons Disease Drug Production, Revenue (Value), Price Trend by Type

4.1 Global Parkinsons Disease Drug Production and Market Share by Type (2014-2019)

4.2 Global Parkinsons Disease Drug Revenue and Market Share by Type (2014-2019)

4.3 Global Parkinsons Disease Drug Price by Type (2014-2019)

4.4 Global Parkinsons Disease Drug Production Growth Rate by Type (2014-2019)

4.4.1 Global Parkinsons Disease Drug Production Growth Rate of Type 1 (2014-2019)

4.4.2 Global Parkinsons Disease Drug Production Growth Rate of Type 2 (2014-2019)

4.4.3 Global Parkinsons Disease Drug Production Growth Rate of Type 3 (2014-2019)

5 Global Parkinsons Disease Drug Market Analysis by Application

5.1 Global Parkinsons Disease Drug Consumption and Market Share by Application (2014-2019)

5.2 Global Parkinsons Disease Drug Consumption Growth Rate by Application (2014-2019)

5.2.1 Global Parkinsons Disease Drug Consumption Growth Rate of Application 1 (2014-2019)

5.2.2 Global Parkinsons Disease Drug Consumption Growth Rate of Application 2 (2014-2019)

5.2.3 Global Parkinsons Disease Drug Consumption Growth Rate of Application 3 (2014-2019)

6 Global Parkinsons Disease Drug Production, Consumption, Export, Import by Region (2014-2019)

6.1 Global Parkinsons Disease Drug Consumption by Region (2014-2019)

6.2 United States Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

6.3 Europe Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

6.4 China Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

6.5 Japan Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

6.6 India Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

6.7 Southeast Asia Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

6.8 Central and South America Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

6.9 Middle East and Africa Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

7 Global Parkinsons Disease Drug Production, Revenue (Value) by Region (2014-2019)

7.1 Global Parkinsons Disease Drug Production and Market Share by Region (2014-2019)

7.2 Global Parkinsons Disease Drug Revenue (Value) and Market Share by Region (2014-2019)

7.3 Global Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

7.4 United States Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

7.5 Europe Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

7.6 China Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

7.7 Japan Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

7.8 India Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

7.9 Southeast Asia Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

7.10 Central and South America Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

7.11 Middle East and Africa Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

8 Parkinsons Disease Drug Manufacturing Analysis

8.1 Parkinsons Disease Drug Key Raw Materials Analysis

8.1.1 Key Raw Materials Introduction

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Manufacturing Cost Analysis

8.2.1 Labor Cost Analysis

8.2.2 Manufacturing Cost Structure Analysis

8.3 Manufacturing Process Analysis of Parkinsons Disease Drug

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Parkinsons Disease Drug Industrial Chain Analysis

9.2 Raw Materials Sources of Parkinsons Disease Drug Major Players in 2018

9.3 Downstream Buyers

10 Market Dynamics

10.1 Drivers

10.2 Restraints

10.3 Opportunities

10.3.1 Advances in Innovation and Technology for Parkinsons Disease Drug

10.3.2 Increased Demand in Emerging Markets

10.4 Challenges

10.4.1 The Performance of Alternative Product Type is Getting Better and Better

10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices

10.5 Porter s Five Forces Analysis

10.5.1 Threat of New Entrants

10.5.2 Threat of Substitutes

10.5.3 Bargaining Power of Suppliers

10.5.4 Bargaining Power of Buyers

10.5.5 Intensity of Competitive Rivalry

11 Global Parkinsons Disease Drug Market Forecast (2019-2026)

11.1 Global Parkinsons Disease Drug Production, Revenue Forecast (2019-2026)

11.1.1 Global Parkinsons Disease Drug Production and Growth Rate Forecast (2019-2026)

11.1.2 Global Parkinsons Disease Drug Revenue and Growth Rate Forecast (2019-2026)

11.1.3 Global Parkinsons Disease Drug Price and Trend Forecast (2019-2026)

11.2 Global Parkinsons Disease Drug Production, Consumption, Export and Import Forecast by Region (2019-2026)

11.2.1 United States Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

11.2.2 Europe Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

11.2.3 China Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

11.2.4 Japan Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

11.2.5 India Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

11.2.6 Southeast Asia Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

11.2.7 Central and South America Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

11.2.8 Middle East and Africa Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

11.3 Global Parkinsons Disease Drug Production, Revenue and Price Forecast by Type (2019-2026)

11.4 Global Parkinsons Disease Drug Consumption Forecast by Application (2019-2026)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology

13.2 Research Data Source


List Of Figure

List of Tables and Figures

Figure Parkinsons Disease Drug Product Picture

Table Global Parkinsons Disease Drug Production and CAGR (%) Comparison by Type

Table Profile of Type 1

Table Profile of Type 2

Table Profile of Type 3

Table Parkinsons Disease Drug Consumption (Sales) Comparison by Application (2014-2026)

Table Profile of Application 1

Table Profile of Application 2

Table Profile of Application 3

Figure Global Parkinsons Disease Drug Market Size (Value) and CAGR (%) (2014-2026)

Figure United States Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Europe Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Germany Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure UK Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure France Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Italy Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Spain Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Russia Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Poland Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure China Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Japan Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure India Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Southeast Asia Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Malaysia Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Singapore Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Philippines Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Indonesia Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Thailand Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Vietnam Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Central and South America Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Brazil Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Mexico Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Colombia Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Middle East and Africa Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Saudi Arabia Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure United Arab Emirates Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Turkey Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Egypt Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure South Africa Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Nigeria Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Global Parkinsons Disease Drug Production Status and Outlook (2014-2026)

Table Global Parkinsons Disease Drug Production by Player (2014-2019)

Table Global Parkinsons Disease Drug Production Share by Player (2014-2019)

Figure Global Parkinsons Disease Drug Production Share by Player in 2018

Table Parkinsons Disease Drug Revenue by Player (2014-2019)

Table Parkinsons Disease Drug Revenue Market Share by Player (2014-2019)

Table Parkinsons Disease Drug Price by Player (2014-2019)

Table Parkinsons Disease Drug Manufacturing Base Distribution and Sales Area by Player

Table Parkinsons Disease Drug Product Type by Player

Table Mergers & Acquisitions, Expansion Plans

Table GSK Profile

Table GSK Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Orion Profile

Table Orion Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Desitin Arzneimittel Profile

Table Desitin Arzneimittel Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table F.Hoffmann-La Roche Profile

Table F.Hoffmann-La Roche Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Akorn Profile

Table Akorn Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Abbvie Profile

Table Abbvie Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Valeant Profile

Table Valeant Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Endo Pharmaceuticals Profile

Table Endo Pharmaceuticals Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Kyowa Hakko Kirin Pharma Profile

Table Kyowa Hakko Kirin Pharma Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Teva Pharmaceutical Profile

Table Teva Pharmaceutical Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Novartis Profile

Table Novartis Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Boehringer Ingelheim Profile

Table Boehringer Ingelheim Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Apokyn Profile

Table Apokyn Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table H.Lundbeck Profile

Table H.Lundbeck Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Merck Profile

Table Merck Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Stada Arzneimittel Profile

Table Stada Arzneimittel Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Astellas Pharma Profile

Table Astellas Pharma Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Global Parkinsons Disease Drug Production by Type (2014-2019)

Table Global Parkinsons Disease Drug Production Market Share by Type (2014-2019)

Figure Global Parkinsons Disease Drug Production Market Share by Type in 2018

Table Global Parkinsons Disease Drug Revenue by Type (2014-2019)

Table Global Parkinsons Disease Drug Revenue Market Share by Type (2014-2019)

Figure Global Parkinsons Disease Drug Revenue Market Share by Type in 2018

Table Parkinsons Disease Drug Price by Type (2014-2019)

Figure Global Parkinsons Disease Drug Production Growth Rate of Type 1 (2014-2019)

Figure Global Parkinsons Disease Drug Production Growth Rate of Type 2 (2014-2019)

Figure Global Parkinsons Disease Drug Production Growth Rate of Type 3 (2014-2019)

Table Global Parkinsons Disease Drug Consumption by Application (2014-2019)

Table Global Parkinsons Disease Drug Consumption Market Share by Application (2014-2019)

Table Global Parkinsons Disease Drug Consumption of Application 1 (2014-2019)

Table Global Parkinsons Disease Drug Consumption of Application 2 (2014-2019)

Table Global Parkinsons Disease Drug Consumption of Application 3 (2014-2019)

Table Global Parkinsons Disease Drug Consumption by Region (2014-2019)

Table Global Parkinsons Disease Drug Consumption Market Share by Region (2014-2019)

Table United States Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

Table Europe Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

Table China Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

Table Japan Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

Table India Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

Table Southeast Asia Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

Table Central and South America Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

Table Middle East and Africa Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

Table Global Parkinsons Disease Drug Production by Region (2014-2019)

Table Global Parkinsons Disease Drug Production Market Share by Region (2014-2019)

Figure Global Parkinsons Disease Drug Production Market Share by Region (2014-2019)

Figure Global Parkinsons Disease Drug Production Market Share by Region in 2018

Table Global Parkinsons Disease Drug Revenue by Region (2014-2019)

Table Global Parkinsons Disease Drug Revenue Market Share by Region (2014-2019)

Figure Global Parkinsons Disease Drug Revenue Market Share by Region (2014-2019)

Figure Global Parkinsons Disease Drug Revenue Market Share by Region in 2018

Table Global Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table United States Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Europe Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table China Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Japan Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table India Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Southeast Asia Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Central and South America Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Middle East and Africa Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Key Raw Materials Introduction of Parkinsons Disease Drug

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Market Concentration Rate of Raw Materials

Figure Manufacturing Cost Structure Analysis

Figure Manufacturing Process Analysis of Parkinsons Disease Drug

Figure Parkinsons Disease Drug Industrial Chain Analysis

Table Raw Materials Sources of Parkinsons Disease Drug Major Players in 2018

Table Downstream Buyers

Figure Global Parkinsons Disease Drug Production and Growth Rate Forecast (2019-2026)

Figure Global Parkinsons Disease Drug Revenue and Growth Rate Forecast (2019-2026)

Figure Global Parkinsons Disease Drug Price and Trend Forecast (2019-2026)

Table United States Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

Table Europe Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

Table China Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

Table Japan Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

Table India Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

Table Southeast Asia Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

Table Southeast Asia Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

Table Middle East and Africa Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

Table Global Parkinsons Disease Drug Market Production Forecast, by Type

Table Global Parkinsons Disease Drug Production Volume Market Share Forecast, by Type

Table Global Parkinsons Disease Drug Market Revenue Forecast, by Type

Table Global Parkinsons Disease Drug Revenue Market Share Forecast, by Type

Table Global Parkinsons Disease Drug Price Forecast, by Type

Table Global Parkinsons Disease Drug Market Production Forecast, by Application

Table Global Parkinsons Disease Drug Production Volume Market Share Forecast, by Application

Table Global Parkinsons Disease Drug Market Revenue Forecast, by Application

Table Global Parkinsons Disease Drug Revenue Market Share Forecast, by Application

Table Global Parkinsons Disease Drug Price Forecast, by Application

Licence Rights

Single User License:

1. The Single User License allows for the use of a report by a single user within one corporate location.

2. The report paper copy may not be reproduced .

3. Report PDF copy cannot be copied (if purchased) and must remain on one computer.

4. Only a single copy of the publication may be printed for internal use.

5.  Users may include information in the report in presentations and internal reports by providing full copyright credit to Maia Research.

6.   Users may not share the report (or any information contained therein) with any other person or persons outside the corporate location for which the report is purchased.

 

Enterprise License:

1. The Enterprise License allows for the use of a report by unlimited users within the purchasing organization.

2. Purchasing organization shall have the right to share the report with third parties. (investors, consultants, etc.) from time to time under the global license agreement, provided that such third parties have a confidentiality agreement with the purchasing organization and agree to be bound by the terms of the global license agreement.

3. Employees of the purchasing organization can include information given in the report in presentations and internal reports by providing full copyright credit to Maia Research.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

The Parkinsons Disease Drug market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.

The report mainly studies the size, recent trends and development status of the Parkinsons Disease Drug market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Parkinsons Disease Drug market.

Major players in the global Parkinsons Disease Drug market include:

GSK

Orion

Desitin Arzneimittel

F.Hoffmann-La Roche

Akorn

Abbvie

Valeant

Endo Pharmaceuticals

Kyowa Hakko Kirin Pharma

Teva Pharmaceutical

Novartis

Boehringer Ingelheim

Apokyn

H.Lundbeck

Merck

Stada Arzneimittel

Astellas Pharma

On the basis of types, the Parkinsons Disease Drug market is primarily split into:

Type 1

Type 2

Type 3

On the basis of applications, the market covers:

Application 1

Application 2

Application 3

Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:

United States

Europe (Germany, UK, France, Italy, Spain, Russia, Poland)

China

Japan

India

Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)

Central and South America (Brazil, Mexico, Colombia)

Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)

Other Regions

Chapter 1 provides an overview of Parkinsons Disease Drug market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Parkinsons Disease Drug market by type, application, and region are also presented in this chapter.

Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.

Chapter 3 provides a full-scale analysis of major players in Parkinsons Disease Drug industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.

Chapter 4 gives a worldwide view of Parkinsons Disease Drug market. It includes production, market share revenue, price, and the growth rate by type.

Chapter 5 focuses on the application of Parkinsons Disease Drug, by analyzing the consumption and its growth rate of each application.

Chapter 6 is about production, consumption, export, and import of Parkinsons Disease Drug in each region.

Chapter 7 pays attention to the production, revenue, price and gross margin of Parkinsons Disease Drug in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.

Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.

Chapter 9 introduces the industrial chain of Parkinsons Disease Drug. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.

Chapter 10 provides clear insights into market dynamics.

Chapter 11 prospects the whole Parkinsons Disease Drug market, including the global production and revenue forecast, regional forecast. It also foresees the Parkinsons Disease Drug market by type and application.

Chapter 12 concludes the research findings and refines all the highlights of the study.

Chapter 13 introduces the research methodology and sources of research data for your understanding.

Years considered for this report:

Historical Years: 2014-2018

Base Year: 2019

Estimated Year: 2019

Forecast Period: 2019-2026

READ MORE

Scope

Table of Contents

1 Parkinsons Disease Drug Market Overview

1.1 Product Overview and Scope of Parkinsons Disease Drug

1.2 Parkinsons Disease Drug Segment by Type

1.2.1 Global Parkinsons Disease Drug Production and CAGR (%) Comparison by Type (2014-2026)

1.2.2 The Market Profile of Type 1

1.2.3 The Market Profile of Type 2

1.2.4 The Market Profile of Type 3

1.3 Global Parkinsons Disease Drug Segment by Application

1.3.1 Parkinsons Disease Drug Consumption (Sales) Comparison by Application (2014-2026)

1.3.2 The Market Profile of Application 1

1.3.3 The Market Profile of Application 2

1.3.4 The Market Profile of Application 3

1.4 Global Parkinsons Disease Drug Market by Region (2014-2026)

1.4.1 Global Parkinsons Disease Drug Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)

1.4.2 United States Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.3 Europe Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.3.1 Germany Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.3.2 UK Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.3.3 France Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.3.4 Italy Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.3.5 Spain Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.3.6 Russia Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.3.7 Poland Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.4 China Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.5 Japan Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.6 India Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.7 Southeast Asia Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.7.1 Malaysia Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.7.2 Singapore Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.7.3 Philippines Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.7.4 Indonesia Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.7.5 Thailand Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.7.6 Vietnam Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.8 Central and South America Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.8.1 Brazil Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.8.2 Mexico Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.8.3 Colombia Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.9 Middle East and Africa Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.9.1 Saudi Arabia Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.9.2 United Arab Emirates Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.9.3 Turkey Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.9.4 Egypt Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.9.5 South Africa Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.4.9.6 Nigeria Parkinsons Disease Drug Market Status and Prospect (2014-2026)

1.5 Global Market Size (Value) of Parkinsons Disease Drug (2014-2026)

1.5.1 Global Parkinsons Disease Drug Revenue Status and Outlook (2014-2026)

1.5.2 Global Parkinsons Disease Drug Production Status and Outlook (2014-2026)

2 Global Parkinsons Disease Drug Market Landscape by Player

2.1 Global Parkinsons Disease Drug Production and Share by Player (2014-2019)

2.2 Global Parkinsons Disease Drug Revenue and Market Share by Player (2014-2019)

2.3 Global Parkinsons Disease Drug Average Price by Player (2014-2019)

2.4 Parkinsons Disease Drug Manufacturing Base Distribution, Sales Area and Product Type by Player

2.5 Parkinsons Disease Drug Market Competitive Situation and Trends

2.5.1 Parkinsons Disease Drug Market Concentration Rate

2.5.2 Parkinsons Disease Drug Market Share of Top 3 and Top 6 Players

2.5.3 Mergers & Acquisitions, Expansion

3 Players Profiles

3.1 GSK

3.1.1 GSK Basic Information, Manufacturing Base, Sales Area and Competitors

3.1.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.1.3 GSK Parkinsons Disease Drug Market Performance (2014-2019)

3.1.4 GSK Business Overview

3.2 Orion

3.2.1 Orion Basic Information, Manufacturing Base, Sales Area and Competitors

3.2.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.2.3 Orion Parkinsons Disease Drug Market Performance (2014-2019)

3.2.4 Orion Business Overview

3.3 Desitin Arzneimittel

3.3.1 Desitin Arzneimittel Basic Information, Manufacturing Base, Sales Area and Competitors

3.3.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.3.3 Desitin Arzneimittel Parkinsons Disease Drug Market Performance (2014-2019)

3.3.4 Desitin Arzneimittel Business Overview

3.4 F.Hoffmann-La Roche

3.4.1 F.Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Competitors

3.4.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.4.3 F.Hoffmann-La Roche Parkinsons Disease Drug Market Performance (2014-2019)

3.4.4 F.Hoffmann-La Roche Business Overview

3.5 Akorn

3.5.1 Akorn Basic Information, Manufacturing Base, Sales Area and Competitors

3.5.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.5.3 Akorn Parkinsons Disease Drug Market Performance (2014-2019)

3.5.4 Akorn Business Overview

3.6 Abbvie

3.6.1 Abbvie Basic Information, Manufacturing Base, Sales Area and Competitors

3.6.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.6.3 Abbvie Parkinsons Disease Drug Market Performance (2014-2019)

3.6.4 Abbvie Business Overview

3.7 Valeant

3.7.1 Valeant Basic Information, Manufacturing Base, Sales Area and Competitors

3.7.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.7.3 Valeant Parkinsons Disease Drug Market Performance (2014-2019)

3.7.4 Valeant Business Overview

3.8 Endo Pharmaceuticals

3.8.1 Endo Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors

3.8.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.8.3 Endo Pharmaceuticals Parkinsons Disease Drug Market Performance (2014-2019)

3.8.4 Endo Pharmaceuticals Business Overview

3.9 Kyowa Hakko Kirin Pharma

3.9.1 Kyowa Hakko Kirin Pharma Basic Information, Manufacturing Base, Sales Area and Competitors

3.9.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.9.3 Kyowa Hakko Kirin Pharma Parkinsons Disease Drug Market Performance (2014-2019)

3.9.4 Kyowa Hakko Kirin Pharma Business Overview

3.10 Teva Pharmaceutical

3.10.1 Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors

3.10.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.10.3 Teva Pharmaceutical Parkinsons Disease Drug Market Performance (2014-2019)

3.10.4 Teva Pharmaceutical Business Overview

3.11 Novartis

3.11.1 Novartis Basic Information, Manufacturing Base, Sales Area and Competitors

3.11.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.11.3 Novartis Parkinsons Disease Drug Market Performance (2014-2019)

3.11.4 Novartis Business Overview

3.12 Boehringer Ingelheim

3.12.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Competitors

3.12.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.12.3 Boehringer Ingelheim Parkinsons Disease Drug Market Performance (2014-2019)

3.12.4 Boehringer Ingelheim Business Overview

3.13 Apokyn

3.13.1 Apokyn Basic Information, Manufacturing Base, Sales Area and Competitors

3.13.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.13.3 Apokyn Parkinsons Disease Drug Market Performance (2014-2019)

3.13.4 Apokyn Business Overview

3.14 H.Lundbeck

3.14.1 H.Lundbeck Basic Information, Manufacturing Base, Sales Area and Competitors

3.14.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.14.3 H.Lundbeck Parkinsons Disease Drug Market Performance (2014-2019)

3.14.4 H.Lundbeck Business Overview

3.15 Merck

3.15.1 Merck Basic Information, Manufacturing Base, Sales Area and Competitors

3.15.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.15.3 Merck Parkinsons Disease Drug Market Performance (2014-2019)

3.15.4 Merck Business Overview

3.16 Stada Arzneimittel

3.16.1 Stada Arzneimittel Basic Information, Manufacturing Base, Sales Area and Competitors

3.16.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.16.3 Stada Arzneimittel Parkinsons Disease Drug Market Performance (2014-2019)

3.16.4 Stada Arzneimittel Business Overview

3.17 Astellas Pharma

3.17.1 Astellas Pharma Basic Information, Manufacturing Base, Sales Area and Competitors

3.17.2 Parkinsons Disease Drug Product Profiles, Application and Specification

3.17.3 Astellas Pharma Parkinsons Disease Drug Market Performance (2014-2019)

3.17.4 Astellas Pharma Business Overview

4 Global Parkinsons Disease Drug Production, Revenue (Value), Price Trend by Type

4.1 Global Parkinsons Disease Drug Production and Market Share by Type (2014-2019)

4.2 Global Parkinsons Disease Drug Revenue and Market Share by Type (2014-2019)

4.3 Global Parkinsons Disease Drug Price by Type (2014-2019)

4.4 Global Parkinsons Disease Drug Production Growth Rate by Type (2014-2019)

4.4.1 Global Parkinsons Disease Drug Production Growth Rate of Type 1 (2014-2019)

4.4.2 Global Parkinsons Disease Drug Production Growth Rate of Type 2 (2014-2019)

4.4.3 Global Parkinsons Disease Drug Production Growth Rate of Type 3 (2014-2019)

5 Global Parkinsons Disease Drug Market Analysis by Application

5.1 Global Parkinsons Disease Drug Consumption and Market Share by Application (2014-2019)

5.2 Global Parkinsons Disease Drug Consumption Growth Rate by Application (2014-2019)

5.2.1 Global Parkinsons Disease Drug Consumption Growth Rate of Application 1 (2014-2019)

5.2.2 Global Parkinsons Disease Drug Consumption Growth Rate of Application 2 (2014-2019)

5.2.3 Global Parkinsons Disease Drug Consumption Growth Rate of Application 3 (2014-2019)

6 Global Parkinsons Disease Drug Production, Consumption, Export, Import by Region (2014-2019)

6.1 Global Parkinsons Disease Drug Consumption by Region (2014-2019)

6.2 United States Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

6.3 Europe Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

6.4 China Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

6.5 Japan Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

6.6 India Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

6.7 Southeast Asia Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

6.8 Central and South America Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

6.9 Middle East and Africa Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

7 Global Parkinsons Disease Drug Production, Revenue (Value) by Region (2014-2019)

7.1 Global Parkinsons Disease Drug Production and Market Share by Region (2014-2019)

7.2 Global Parkinsons Disease Drug Revenue (Value) and Market Share by Region (2014-2019)

7.3 Global Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

7.4 United States Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

7.5 Europe Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

7.6 China Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

7.7 Japan Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

7.8 India Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

7.9 Southeast Asia Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

7.10 Central and South America Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

7.11 Middle East and Africa Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

8 Parkinsons Disease Drug Manufacturing Analysis

8.1 Parkinsons Disease Drug Key Raw Materials Analysis

8.1.1 Key Raw Materials Introduction

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Manufacturing Cost Analysis

8.2.1 Labor Cost Analysis

8.2.2 Manufacturing Cost Structure Analysis

8.3 Manufacturing Process Analysis of Parkinsons Disease Drug

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Parkinsons Disease Drug Industrial Chain Analysis

9.2 Raw Materials Sources of Parkinsons Disease Drug Major Players in 2018

9.3 Downstream Buyers

10 Market Dynamics

10.1 Drivers

10.2 Restraints

10.3 Opportunities

10.3.1 Advances in Innovation and Technology for Parkinsons Disease Drug

10.3.2 Increased Demand in Emerging Markets

10.4 Challenges

10.4.1 The Performance of Alternative Product Type is Getting Better and Better

10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices

10.5 Porter s Five Forces Analysis

10.5.1 Threat of New Entrants

10.5.2 Threat of Substitutes

10.5.3 Bargaining Power of Suppliers

10.5.4 Bargaining Power of Buyers

10.5.5 Intensity of Competitive Rivalry

11 Global Parkinsons Disease Drug Market Forecast (2019-2026)

11.1 Global Parkinsons Disease Drug Production, Revenue Forecast (2019-2026)

11.1.1 Global Parkinsons Disease Drug Production and Growth Rate Forecast (2019-2026)

11.1.2 Global Parkinsons Disease Drug Revenue and Growth Rate Forecast (2019-2026)

11.1.3 Global Parkinsons Disease Drug Price and Trend Forecast (2019-2026)

11.2 Global Parkinsons Disease Drug Production, Consumption, Export and Import Forecast by Region (2019-2026)

11.2.1 United States Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

11.2.2 Europe Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

11.2.3 China Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

11.2.4 Japan Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

11.2.5 India Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

11.2.6 Southeast Asia Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

11.2.7 Central and South America Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

11.2.8 Middle East and Africa Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

11.3 Global Parkinsons Disease Drug Production, Revenue and Price Forecast by Type (2019-2026)

11.4 Global Parkinsons Disease Drug Consumption Forecast by Application (2019-2026)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology

13.2 Research Data Source


List Of Figure

List of Tables and Figures

Figure Parkinsons Disease Drug Product Picture

Table Global Parkinsons Disease Drug Production and CAGR (%) Comparison by Type

Table Profile of Type 1

Table Profile of Type 2

Table Profile of Type 3

Table Parkinsons Disease Drug Consumption (Sales) Comparison by Application (2014-2026)

Table Profile of Application 1

Table Profile of Application 2

Table Profile of Application 3

Figure Global Parkinsons Disease Drug Market Size (Value) and CAGR (%) (2014-2026)

Figure United States Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Europe Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Germany Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure UK Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure France Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Italy Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Spain Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Russia Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Poland Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure China Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Japan Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure India Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Southeast Asia Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Malaysia Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Singapore Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Philippines Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Indonesia Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Thailand Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Vietnam Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Central and South America Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Brazil Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Mexico Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Colombia Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Middle East and Africa Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Saudi Arabia Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure United Arab Emirates Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Turkey Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Egypt Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure South Africa Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Nigeria Parkinsons Disease Drug Revenue and Growth Rate (2014-2026)

Figure Global Parkinsons Disease Drug Production Status and Outlook (2014-2026)

Table Global Parkinsons Disease Drug Production by Player (2014-2019)

Table Global Parkinsons Disease Drug Production Share by Player (2014-2019)

Figure Global Parkinsons Disease Drug Production Share by Player in 2018

Table Parkinsons Disease Drug Revenue by Player (2014-2019)

Table Parkinsons Disease Drug Revenue Market Share by Player (2014-2019)

Table Parkinsons Disease Drug Price by Player (2014-2019)

Table Parkinsons Disease Drug Manufacturing Base Distribution and Sales Area by Player

Table Parkinsons Disease Drug Product Type by Player

Table Mergers & Acquisitions, Expansion Plans

Table GSK Profile

Table GSK Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Orion Profile

Table Orion Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Desitin Arzneimittel Profile

Table Desitin Arzneimittel Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table F.Hoffmann-La Roche Profile

Table F.Hoffmann-La Roche Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Akorn Profile

Table Akorn Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Abbvie Profile

Table Abbvie Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Valeant Profile

Table Valeant Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Endo Pharmaceuticals Profile

Table Endo Pharmaceuticals Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Kyowa Hakko Kirin Pharma Profile

Table Kyowa Hakko Kirin Pharma Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Teva Pharmaceutical Profile

Table Teva Pharmaceutical Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Novartis Profile

Table Novartis Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Boehringer Ingelheim Profile

Table Boehringer Ingelheim Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Apokyn Profile

Table Apokyn Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table H.Lundbeck Profile

Table H.Lundbeck Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Merck Profile

Table Merck Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Stada Arzneimittel Profile

Table Stada Arzneimittel Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Astellas Pharma Profile

Table Astellas Pharma Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Global Parkinsons Disease Drug Production by Type (2014-2019)

Table Global Parkinsons Disease Drug Production Market Share by Type (2014-2019)

Figure Global Parkinsons Disease Drug Production Market Share by Type in 2018

Table Global Parkinsons Disease Drug Revenue by Type (2014-2019)

Table Global Parkinsons Disease Drug Revenue Market Share by Type (2014-2019)

Figure Global Parkinsons Disease Drug Revenue Market Share by Type in 2018

Table Parkinsons Disease Drug Price by Type (2014-2019)

Figure Global Parkinsons Disease Drug Production Growth Rate of Type 1 (2014-2019)

Figure Global Parkinsons Disease Drug Production Growth Rate of Type 2 (2014-2019)

Figure Global Parkinsons Disease Drug Production Growth Rate of Type 3 (2014-2019)

Table Global Parkinsons Disease Drug Consumption by Application (2014-2019)

Table Global Parkinsons Disease Drug Consumption Market Share by Application (2014-2019)

Table Global Parkinsons Disease Drug Consumption of Application 1 (2014-2019)

Table Global Parkinsons Disease Drug Consumption of Application 2 (2014-2019)

Table Global Parkinsons Disease Drug Consumption of Application 3 (2014-2019)

Table Global Parkinsons Disease Drug Consumption by Region (2014-2019)

Table Global Parkinsons Disease Drug Consumption Market Share by Region (2014-2019)

Table United States Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

Table Europe Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

Table China Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

Table Japan Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

Table India Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

Table Southeast Asia Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

Table Central and South America Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

Table Middle East and Africa Parkinsons Disease Drug Production, Consumption, Export, Import (2014-2019)

Table Global Parkinsons Disease Drug Production by Region (2014-2019)

Table Global Parkinsons Disease Drug Production Market Share by Region (2014-2019)

Figure Global Parkinsons Disease Drug Production Market Share by Region (2014-2019)

Figure Global Parkinsons Disease Drug Production Market Share by Region in 2018

Table Global Parkinsons Disease Drug Revenue by Region (2014-2019)

Table Global Parkinsons Disease Drug Revenue Market Share by Region (2014-2019)

Figure Global Parkinsons Disease Drug Revenue Market Share by Region (2014-2019)

Figure Global Parkinsons Disease Drug Revenue Market Share by Region in 2018

Table Global Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table United States Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Europe Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table China Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Japan Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table India Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Southeast Asia Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Central and South America Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Middle East and Africa Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

Table Key Raw Materials Introduction of Parkinsons Disease Drug

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Market Concentration Rate of Raw Materials

Figure Manufacturing Cost Structure Analysis

Figure Manufacturing Process Analysis of Parkinsons Disease Drug

Figure Parkinsons Disease Drug Industrial Chain Analysis

Table Raw Materials Sources of Parkinsons Disease Drug Major Players in 2018

Table Downstream Buyers

Figure Global Parkinsons Disease Drug Production and Growth Rate Forecast (2019-2026)

Figure Global Parkinsons Disease Drug Revenue and Growth Rate Forecast (2019-2026)

Figure Global Parkinsons Disease Drug Price and Trend Forecast (2019-2026)

Table United States Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

Table Europe Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

Table China Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

Table Japan Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

Table India Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

Table Southeast Asia Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

Table Southeast Asia Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

Table Middle East and Africa Parkinsons Disease Drug Production, Consumption, Export and Import Forecast (2019-2026)

Table Global Parkinsons Disease Drug Market Production Forecast, by Type

Table Global Parkinsons Disease Drug Production Volume Market Share Forecast, by Type

Table Global Parkinsons Disease Drug Market Revenue Forecast, by Type

Table Global Parkinsons Disease Drug Revenue Market Share Forecast, by Type

Table Global Parkinsons Disease Drug Price Forecast, by Type

Table Global Parkinsons Disease Drug Market Production Forecast, by Application

Table Global Parkinsons Disease Drug Production Volume Market Share Forecast, by Application

Table Global Parkinsons Disease Drug Market Revenue Forecast, by Application

Table Global Parkinsons Disease Drug Revenue Market Share Forecast, by Application

Table Global Parkinsons Disease Drug Price Forecast, by Application

Single User License:

1. The Single User License allows for the use of a report by a single user within one corporate location.

2. The report paper copy may not be reproduced .

3. Report PDF copy cannot be copied (if purchased) and must remain on one computer.

4. Only a single copy of the publication may be printed for internal use.

5.  Users may include information in the report in presentations and internal reports by providing full copyright credit to Maia Research.

6.   Users may not share the report (or any information contained therein) with any other person or persons outside the corporate location for which the report is purchased.

 

Enterprise License:

1. The Enterprise License allows for the use of a report by unlimited users within the purchasing organization.

2. Purchasing organization shall have the right to share the report with third parties. (investors, consultants, etc.) from time to time under the global license agreement, provided that such third parties have a confidentiality agreement with the purchasing organization and agree to be bound by the terms of the global license agreement.

3. Employees of the purchasing organization can include information given in the report in presentations and internal reports by providing full copyright credit to Maia Research.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS